177 related articles for article (PubMed ID: 28295165)
1. Declining invasive prenatal diagnostic procedures: A comparison of tertiary hospital and national data from 2012 to 2015.
Johnson K; Kelley J; Saxton V; Walker SP; Hui L
Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):152-156. PubMed ID: 28295165
[TBL] [Abstract][Full Text] [Related]
2. Invasive prenatal diagnostic practice in Denmark 1996 to 2006.
Vestergaard CH; Lidegaard Ø; Tabor A
Acta Obstet Gynecol Scand; 2009; 88(3):362-5. PubMed ID: 19172424
[TBL] [Abstract][Full Text] [Related]
3. Uptake of noninvasive prenatal testing at a large academic referral center.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
[TBL] [Abstract][Full Text] [Related]
4. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
5. Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016.
Lostchuck E; Poulton A; Halliday J; Hui L
Ultrasound Obstet Gynecol; 2019 Apr; 53(4):503-511. PubMed ID: 29877030
[TBL] [Abstract][Full Text] [Related]
6. Chorionic villus sampling in the cell-free DNA aneuploidy screening era: careful selection criteria can maximise the clinical utility of screening and invasive testing.
Kane SC; Reidy KL; Norris F; Nisbet DL; Kornman LH; Palma-Dias R
Prenat Diagn; 2017 Apr; 37(4):399-408. PubMed ID: 28207933
[TBL] [Abstract][Full Text] [Related]
7. Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older.
Zoppi MA; Ibba RM; Putzolu M; Floris M; Monni G
Obstet Gynecol; 2001 Jun; 97(6):916-20. PubMed ID: 11384696
[TBL] [Abstract][Full Text] [Related]
8. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age.
Nakata N; Wang Y; Bhatt S
Prenat Diagn; 2010 Mar; 30(3):198-206. PubMed ID: 20063323
[TBL] [Abstract][Full Text] [Related]
9. National decline in invasive prenatal diagnostic procedures in association with uptake of combined first trimester and cell-free DNA aneuploidy screening.
Robson SJ; Hui L
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):507-10. PubMed ID: 26259499
[TBL] [Abstract][Full Text] [Related]
10. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study.
Tabor A; Vestergaard CH; Lidegaard Ø
Ultrasound Obstet Gynecol; 2009 Jul; 34(1):19-24. PubMed ID: 19504504
[TBL] [Abstract][Full Text] [Related]
11. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
Chasen ST; McCullough LB; Chervenak FA
Am J Obstet Gynecol; 2004 Mar; 190(3):769-74. PubMed ID: 15042012
[TBL] [Abstract][Full Text] [Related]
12. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
[TBL] [Abstract][Full Text] [Related]
13. The impact of utilization of early aneuploidy screening on amniocenteses available for training in obstetrics and fetal medicine.
Rose NC; Lagrave D; Hafen B; Jackson M
Prenat Diagn; 2013 Mar; 33(3):242-4. PubMed ID: 23354826
[TBL] [Abstract][Full Text] [Related]
14. Changes in the utilization of prenatal diagnosis.
Benn PA; Egan JF; Fang M; Smith-Bindman R
Obstet Gynecol; 2004 Jun; 103(6):1255-60. PubMed ID: 15172861
[TBL] [Abstract][Full Text] [Related]
15. [Contribution of array CGH in the management of fetal nuchal translucency].
Beal J; Jedraszak G; Saliou AH; Copin H; Sergent F; Gondry J; Merviel P; Muszynski C
Gynecol Obstet Fertil Senol; 2020 Feb; 48(2):174-180. PubMed ID: 31634590
[TBL] [Abstract][Full Text] [Related]
16. Emerging issues in invasive prenatal diagnosis: Safety and competency in the post-NIPT era.
Hui L; The S; McCarthy EA; Walker SP
Aust N Z J Obstet Gynaecol; 2015 Dec; 55(6):541-6. PubMed ID: 26303213
[TBL] [Abstract][Full Text] [Related]
17. A retrospective exploratory study of fetal genetic invasive procedures at a University Hospital.
Andrew C; Koshy T; Gopal S; Paul SFD
J Obstet Gynaecol; 2018 Oct; 38(7):906-910. PubMed ID: 29553859
[TBL] [Abstract][Full Text] [Related]
18. Population-based trends in prenatal screening and diagnosis for aneuploidy: a retrospective analysis of 38 years of state-wide data.
Hui L; Muggli EE; Halliday JL
BJOG; 2016 Jan; 123(1):90-7. PubMed ID: 26108969
[TBL] [Abstract][Full Text] [Related]
19. [Chorionic villus needle sampling by the transabdominal route or by placental centesis. A series of 930 cases].
Guidicelli B; Levy A; Piquet C; Gamerre M
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(8):851-5. PubMed ID: 8132961
[TBL] [Abstract][Full Text] [Related]
20. Trends in the utilization of invasive prenatal diagnosis in The Netherlands during 2000-2009.
Lichtenbelt KD; Alizadeh BZ; Scheffer PG; Stoutenbeek P; Schielen PC; Page-Christiaens LC; Schuring-Blom GH
Prenat Diagn; 2011 Aug; 31(8):765-72. PubMed ID: 21692084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
